Functional Outcomes and Control Using Synchron BCI - Canada

Sponsor
Synchron, Inc.
Study ID
NCT07446114
Status
Recruiting
Apply to this trial

Conditions

  • ALS
  • Motor Neuron Disease
  • Neurologic Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Stentrode — DEVICE
    The Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.

Study Details

Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN)

Key Dates

Start date
Mar 18, 2026
Status verified
Apr 2026
Primary completion
Dec 31, 2026
Completion
Jul 31, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Single
    Single Arm

Primary Outcome Measure

Device-related serious adverse events resulting in death or permanently increased disability up to 90 days after implant. [ Time Frame: 3 Months ]

Central Contacts

Related Studies